Trial · NCT07893184
Feasibility of Physical Prehabilitation for High-Risk Patients Undergoing Cardiac Surgery Via Sternotomy
NCT07893184, Not applicable, Enrolling by invitation, Maastricht University Medical Center
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Feasibility of Physical Prehabilitation for High-Risk Patients Undergoing Cardiac Surgery Via Sternotomy. Trials, record NCT07893184. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07893184
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Feasibility of Physical Prehabilitation for High-Risk Patients Undergoing Cardiac Surgery Via Sternotomy
- NCT number
- NCT07893184
- Status
- Enrolling by invitation
- Phases
- Not applicable
- Enrollment
- 24 participants, estimated
- Lead sponsor
- Maastricht University Medical Center
- Conditions
- Prehabilitation, Cardiac Surgery, Risk Assesment, Aortic Valve, Coronary Artery Bypass Graft, Training
- Interventions
- Physical Prehabilitation Intervention
- First posted
- 2026-10-23
- Last updated
- 2026-10-23
Source ClinicalTrials.gov
Registered outcomes22
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Recruitment - Recruitment rate | Week 0 | Number of included patients within the study period (n,%) |
| Primary | Recruitment (Ineligibility rate due to CPET safety criteria | Week 0 | Number of patients withdrawn due to safety criteria (n,%) |
| Primary | Adherence - Attendance rate for physiotherapist-supervised groups sessions | Week 0-4~6 | Number of attended sessions / total number of planned sessions (n,%) |
| Primary | Adherence rate - Exercise Relative Dose Intensity ExRDI cardiorespiratory training (%) | Week 0-4~6 | ExRDI cardiorespiratory training = completed exercise dose intensity / prescribed exercise dose intensity. Interval training (CABG) • Completed = Σ (completed work-interval duration \[min\] × completed work rate \[WR\]). • Prescribed = Σ (prescribed work-interval duration \[min\] × prescribed work rate \[WR\]). Continuous training (AVR) • Completed = total completed duration \[min\] × completed work rate \[WR\]. • Prescribed = total prescribed duration \[min\] × prescribed work rate \[WR\]. ExRDI cardiorespiratory training is calculated for each participant individually, cumulative for all training sessions; and cumulative for all participants. |
| Primary | Adherence rate - EXRDI peripheral strength training (%) | Week 0-4~6 | ExRDI peripheral strength training = completed exercise dose intensity / prescribed exercise dose intensity. * Completed = completed weight \[kg\] × sets \[N\] × repetitions \[N\] per exercise. * Prescribed = prescribed weight \[kg\] × sets \[N\] × repetitions \[N\] per exercise. ExRDI peripheral strength training is calculated per participant per training session for each exercise and for all four exercises cumulative. And cumulative for all training sessions; and cumulative for all participants. |
| Primary | Adherence rate - ErXDI inspiratory strength training (%) | Week 0-4~6 | ExRDI inspiratory strength training = completed exercise dose intensity / prescribed exercise dose intensity. * Completed volume = completed resistance × sets \[N\] × repetitions \[N\]. * Prescribed volume = prescribed resistance × sets \[N\] × repetitions \[N\]. ExRDI inspiratory strength training will be calculated once weekly for each participant during the supervised training session. The weekly value will be accumulated across all supervised sessions and aggregated across participants. For unsupervised inspiratory strength training, diary entries will be reviewed with the participant during the weekly supervised session. Patients will record the number of sets and repetitions performed each day, from which the completed exercise dose intensity will be derived. Prescribed volumes will be based on the individual's target resistance, sets, and repetitions for that week. Supervised and unsupervised ExRDI values will be calculated and analyzed separately. |
| Primary | Adherence - ExRDI Physical activity and unsupervised home-based exercises (%) | Week 0-4~6 | ExRDI physical activity and unsupervised home-based exerises = completed physical activity volume / prescribed physical activity volume. * Completed volume = PAM measured activity (min/day) * Prescribed volume = goal activity (min/day) ExRDI physical activity and unsupervised home-based exercises is calculated and evaluated per participant in the week during supervised training session. And cumulative for all weeks; and cumulative for all participants. |
| Primary | Reasons for not having executed a training session as intended | Week 0-4~6 | Reasons for not having executed a training session as intended (e.g., low saturation, high blood pressure, the intended training intensity could not be sustained, tiredness, etc.) |
| Primary | Reasons for not having executed a training session as intended stratified by trainings type | Week 0-4~6 | Reasons for not having executed a training session as intended (e.g., low saturation, high blood pressure, the intended training intensity could not be sustained, tiredness, etc.) |
| Primary | Drop-out rate (%) | Week 0-4~6 | Number of participants who dropped out divided by the total number of participants |
1 to 10 of 22Source ClinicalTrials.gov
See all 22 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers5
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07893184
GET https://conductscience.org/api/trials/v1/NCT07893184/registered?page=2